microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63:11–30.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Heymach JV, Lippman SM. Lung cancer. New Engl J Med. 2008;359:1367–1380.
   PubMed Web of Science ®Google Scholar
• Mercier O, Fadel E, de Perrot M, et al. Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer. J Thoracic Cardiovasc Surg. 2005;130:136–140.
   PubMed Web of Science ®Google Scholar
• Blais N, Kassouf E. Maintenance therapies for non-small cell lung cancer. Front Oncol. 2014;4:213.
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Xu L, Xu X, Huang H, et al. MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK. Pathol Res Pract. 2018;214:776–783.
   PubMed Web of Science ®Google Scholar
• Dou L, Han K, Xiao M, et al. MiR-223-5p suppresses tumor growth and metastasis in non-small cell lung cancer by targeting E2F8. Oncol Res. 2018. [Epub ahead of print] PMID: 29615147. DOI:10.3727/096504018X15219188894056
   PubMedGoogle Scholar
• Peng B, Li C, Cai P, et al. Knockdown of miR-935 increases paclitaxel sensitivity via regulation of SOX7 in non-small-cell lung cancer. Mol Med Rep. 2018;18:3397–3402.
   PubMed Web of Science ®Google Scholar
• Yang M, Cui G, Ding M, Yang W, Liu Y, Dai D, et al. miR-935 promotes gastric cancer cell proliferation by targeting SOX7. Biomed Pharmacol. 2016;79:153–158.
   PubMed Web of Science ®Google Scholar
• Yan C, Yu J, Kang W, et al. miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression. Biochem Biophysical Res Commun. 2016;470:68–74.
   PubMed Web of Science ®Google Scholar
• Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nature Rev Cancer. 2009;9:785–797.
   PubMed Web of Science ®Google Scholar
• Di Stefano L, Jensen MR. E2f7 HK, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 2003;22:6289–6298.
   PubMed Web of Science ®Google Scholar
• Chu J, Zhu Y, Liu Y, et al. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter. Oncotarget. 2015;6:31944–31957.
   PubMedGoogle Scholar
• Mitxelena J, Apraiz A, Vallejo-Rodriguez J, et al. E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation. Nucleic Acids Res. 2016;44:5557–5570.
   Web of Science ®Google Scholar
• Mahmood MQ, Ward C, Muller HK, et al. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Medical Oncol. 2017;34:45.
   PubMed Web of Science ®Google Scholar
• Jakubikova J, Sedlak J, Mithen R, et al. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol. 2005;69:1543–1552.
   PubMed Web of Science ®Google Scholar
• Li D, He C, Wang J, et al. MicroRNA-138 inhibits cell growth, invasion, and EMT of non-small cell lung cancer via SOX4/p53 Feedback Loop. Oncol Res. 2017. DOI:10.3727/096504017X14973124850905.
   Google Scholar
• Tang T, Huan L, Zhang S, et al. MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4. Oncol Rep. 2017;38:2243–2250.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang Y, Zhang X. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/beta-catenin pathway in non-small cell lung cancer. Life Sciences. 2017;188:163–171.
   PubMed Web of Science ®Google Scholar
• Wei Y, He R, Wu Y, et al. Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues. Tumour Biol. 2016;37:12555–12569.
   PubMedGoogle Scholar
• Xu C, Zheng Y, Lian D, et al. Analysis of microRNA expression profile identifies novel biomarkers for non-small cell lung cancer. Tumori. 2015;101:104–110.
   PubMed Web of Science ®Google Scholar
• Liu X, Li J, Yu Z, et al. miR-935 promotes liver cancer cell proliferation and migration by targeting SOX7. Oncol Res. 2017;25:427–435.
   PubMed Web of Science ®Google Scholar
• Wang C, Feng Z, Jiang K, et al. Upregulation of microRNA-935 promotes the malignant behaviors of pancreatic carcinoma PANC-1 cells via targeting inositol polyphosphate 4-phosphatase type I gene (INPP4A). Oncol Res. 2017;25:559–569.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li Q, Zhao X, et al. MicroRNA-935 inhibits proliferation and invasion of osteosarcoma cells by directly targeting high mobility group box 1. Oncol Res. 2018.
   Google Scholar
• de Bruin A, Maiti B, Jakoi L, et al. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem. 2003;278:42041–42049.
   PubMedGoogle Scholar
• Li Q, Qiu XM, Li QH, et al. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. Oncol Rep. 2015;33:2354–2360.
   PubMed Web of Science ®Google Scholar
• Ye YY, Mei JW, Xiang SS, et al. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Cell Death Dis. 2018;9:410.
   PubMed Web of Science ®Google Scholar
• Salvatori B, Iosue I, Mangiavacchi A, et al. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis. 2012;3:e413.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Y, Shi Y, et al. MiR-129 triggers autophagic flux by regulating a novel Notch-1/E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells. Oncotarget. 2016;7:9222–9235.
   PubMedGoogle Scholar
• Lee SI, Jeon MH, Kim JS, et al. The miR-302 cluster transcriptionally regulated by POUV, SOX and STAT5B controls the undifferentiated state through the post-transcriptional repression of PBX3 and E2F7 in early chick development. Mol Reprod Dev. 2014;81:1103–1114.
   PubMed Web of Science ®Google Scholar
• Lu C, Shan Z, Hong J, et al. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Int J Oncol. 2017;51:235–244.
   PubMed Web of Science ®Google Scholar
• Wen XP, Ma HL, Zhao LY, et al. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R. Cell Mol Biol. 2015;61:78–85.
   PubMed Web of Science ®Google Scholar